Showing results (1171-1180 of 1,201) with videos related to

Sort By:
Pageof 121
Frontiers in Oncology|August 1, 2022
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS TrialMagnus Nilsson, Halla Olafsdottir, Gabriella Alexandersson von Döbeln, et al.
Annals of Surgery|November 12, 2020
Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE): Results From the Multicenter International RegistryB Feike Kingma, Peter P Grimminger, Pieter C van der Sluis, et al.
The British Journal of Surgery|February 22, 2024
Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinomaSofie P G Henckens, Dajia Liu, Suzanne S Gisbertz, et al.
United European Gastroenterology Journal|October 5, 2021
Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinomaSteffi E M van de Ven, Lucia Suzuki, Annieke W Gotink, et al.
American Journal of Medical Genetics. Part A|March 10, 2022
The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discoveryMaria I Kontaridis, Amy E Roberts, Lisa Schill, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 29, 2022
Body Composition Is a Predictor for Postoperative Complications After Gastrectomy for Gastric Cancer: a Prospective Side Study of the LOGICA TrialThaís T T Tweed, Arjen van der Veen, Stan Tummers, et al.
Endoscopy|February 24, 2021
Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort studyAnnieke W Gotink, Steffi E M van de Ven, Fiebo J C Ten Kate, et al.
Blood|June 13, 2018
Identification of a new <i>VHL</i> exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau diseaseMarion Lenglet, Florence Robriquet, Klaus Schwarz, et al.
BMC Cancer|November 27, 2025
[<sup>18</sup>F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study)Lianne Triemstra, Sarah W J M Spruijt, Dennis Vriens, et al.
Journal of Medical Genetics|May 17, 2015
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriersRachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, et al.
Pageof 121